Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry
- 1 September 1995
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 712 (1) , 61-66
- https://doi.org/10.1016/0021-9673(95)00288-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- New platinum antitumor complexesPublished by Elsevier ,1993
- Ammine/amine platinum (IV) dicarboxylates: A lead to the discovery of a new generation of broad spectrum platinum-based anticancer drugsDrugs of the Future, 1993
- Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesBritish Journal of Cancer, 1992
- Electrospray ionization mass spectrometry of platinum anticancer agentsJournal of Mass Spectrometry, 1991
- Studies on the human metabolism of iproplatinCancer Chemotherapy and Pharmacology, 1989
- Uptake and metabolism of iproplatin in murine L1210 cellsCancer Chemotherapy and Pharmacology, 1989
- Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromJournal of Chromatography A, 1987
- Physiological model for the pharmacokinetics ofcis-dichlorodiammineplatinum(II) (DDP) in the tumored ratJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Effects of antimitotic agents bound to a macromolecular carrier in normal or cancer cells. Importance of the mode of binding of the agent to the carrierPublished by Elsevier ,1978
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969